Barry Kaufman

445 total citations
11 papers, 348 citations indexed

About

Barry Kaufman is a scholar working on Surgery, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Barry Kaufman has authored 11 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 2 papers in Public Health, Environmental and Occupational Health and 1 paper in Molecular Biology. Recurrent topics in Barry Kaufman's work include Esophageal and GI Pathology (2 papers), Gastrointestinal disorders and treatments (2 papers) and Spinal Dysraphism and Malformations (2 papers). Barry Kaufman is often cited by papers focused on Esophageal and GI Pathology (2 papers), Gastrointestinal disorders and treatments (2 papers) and Spinal Dysraphism and Malformations (2 papers). Barry Kaufman collaborates with scholars based in United States and United Kingdom. Barry Kaufman's co-authors include George C. Cotzias, Ismael F. Mena, Paul S. Papavasiliou, Clas Fehling, Rosemary Biggs, PB Kernoff, A. L. Bloom, P N Walsh, Jacqueline M. Matthews and Peter Beck and has published in prestigious journals such as New England Journal of Medicine, The American Journal of Gastroenterology and Neurosurgery.

In The Last Decade

Barry Kaufman

10 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Kaufman United States 4 148 87 79 30 29 11 348
George Belendiuk United States 9 316 2.1× 5 0.1× 45 0.6× 16 0.5× 84 2.9× 12 601
Tony Waegemans France 7 110 0.7× 42 0.5× 146 1.8× 10 0.3× 222 7.7× 12 496
Richard D. Scheyer United States 9 104 0.7× 41 0.5× 92 1.2× 4 0.1× 159 5.5× 15 511
B Schulze Germany 6 46 0.3× 10 0.1× 63 0.8× 7 0.2× 39 1.3× 21 248
L. Crescibene Italy 9 200 1.4× 9 0.1× 69 0.9× 4 0.1× 19 0.7× 17 347
K. Raikoff United States 7 69 0.5× 12 0.1× 80 1.0× 47 1.6× 10 0.3× 13 360
Karen García United States 4 22 0.1× 18 0.2× 52 0.7× 4 0.1× 5 0.2× 5 573
H Umezaki Japan 9 36 0.2× 5 0.1× 46 0.6× 5 0.2× 20 0.7× 23 298
N. Sayre United States 11 38 0.3× 10 0.1× 45 0.6× 7 0.2× 18 0.6× 18 386
S Santandrea Italy 9 19 0.1× 47 0.5× 9 0.1× 10 0.3× 98 3.4× 13 294

Countries citing papers authored by Barry Kaufman

Since Specialization
Citations

This map shows the geographic impact of Barry Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Kaufman more than expected).

Fields of papers citing papers by Barry Kaufman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Kaufman. The network helps show where Barry Kaufman may publish in the future.

Co-authorship network of co-authors of Barry Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Kaufman. A scholar is included among the top collaborators of Barry Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Kaufman. Barry Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kaufman, Barry, Robert Hardi, Ronald E. Pruitt, et al.. (2012). Novel STAT3 Selective Inhibitor Natura-α Shows Great Promises in Treating Moderate-to-severe Ulcerative Colitis in a Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial. The American Journal of Gastroenterology. 107. S638–S638. 1 indexed citations
2.
Friedlaender, Michael M., Barry Kaufman, Dvora Rubinger, & Raphael Gorodetsky. (1987). Normal skin zinc content in hemodialysis patients. 4(3). 105–106. 1 indexed citations
3.
Anand, Azad K., et al.. (1985). Cervical Diastematomyelia: A Case Report with Operative Management. Neurosurgery. 16(4). 538–542. 4 indexed citations
4.
Anand, Azad K., et al.. (1985). Cervical Diastematomyelia: A Case Report with Operative Management. Neurosurgery. 16(4). 538–542. 3 indexed citations
5.
Kaufman, Barry, et al.. (1983). [Missed bilateral anterior dislocation of the shoulder following convulsions].. PubMed. 105(9). 266–266. 5 indexed citations
6.
Kaufman, Barry, et al.. (1976). Systemic absorption of contrast agent during endoscopic retrograde cholangiopancreatography. Gastrointestinal Endoscopy. 22(3). 175–176. 3 indexed citations
7.
Raskin, Jeffrey B. & Barry Kaufman. (1976). Indications and therapeutic applications of gastrointestinal endoscopy.. PubMed. 2(8). 42–52.
8.
Kaufman, Barry, et al.. (1976). Schistosoma mansoni infection of the colon: A case report and review of the late colonic manifestations. Digestive Diseases and Sciences. 21(11). 988–991. 3 indexed citations
9.
Kaufman, Barry. (1973). Books. The Urban Review. 6(4). 45–47. 1 indexed citations
10.
Walsh, P N, C. R. Rizza, Jacqueline M. Matthews, et al.. (1971). Epsilon‐Aminocaproic Acid Therapy for Dental Extractions in Haemophilia and Christmas Disease: A Double Blind Controlled Trial. British Journal of Haematology. 20(5). 463–475. 109 indexed citations
11.
Cotzias, George C., Paul S. Papavasiliou, Clas Fehling, Barry Kaufman, & Ismael F. Mena. (1970). Similarities between Neurologic Effects of L-Dopa and of Apomorphine. New England Journal of Medicine. 282(1). 31–33. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026